Works by Isobe, Hiroshi


Results: 64
    1

    Theoretical elucidation of the structure, bonding, and reactivity of the CaMn<sub>4</sub>O<sub>x</sub> clusters in the whole Kok cycle for water oxidation embedded in the oxygen evolving center of photosystem II. New molecular and quantum insights into the mechanism of the O–O bond formation

    Published in:
    Photosynthesis Research, 2024, v. 162, n. 2, p. 291, doi. 10.1007/s11120-023-01053-7
    By:
    • Yamaguchi, Kizashi;
    • Miyagawa, Koichi;
    • Shoji, Mitsuo;
    • Kawakami, Takashi;
    • Isobe, Hiroshi;
    • Yamanaka, Shusuke;
    • Nakajima, Takahito
    Publication type:
    Article
    2

    Phase II Study of Irinotecan plus S-1 Combination for Previously Untreated Advanced Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601.

    Published in:
    Oncology, 2011, v. 81, n. 2, p. 84, doi. 10.1159/000331681
    By:
    • Akie, Kenji;
    • Oizumi, Satoshi;
    • Ogura, Shigeaki;
    • Shinagawa, Naofumi;
    • Kikuchi, Eiki;
    • Fukumoto, Shinichi;
    • Harada, Masao;
    • Kinoshita, Ichiro;
    • Kojima, Tetsuya;
    • Harada, Toshiyuki;
    • Fujita, Yuka;
    • Ohsaki, Yoshinobu;
    • Dosaka-Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Nishimura, Masaharu
    Publication type:
    Article
    3
    4
    5
    6
    7

    Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157
    By:
    • Saka, Hideo;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Horinouchi, Hidehito;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Yada, Nobumichi
    Publication type:
    Article
    8
    9

    Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer--data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002).

    Published in:
    Japanese Journal of Clinical Oncology, 2015, v. 45, n. 7, p. 670, doi. 10.1093/jjco/hyv054
    By:
    • Eisaku Miyauchi;
    • Akira Inoue;
    • Kunihiko Kobayashi;
    • Makoto Maemondo;
    • Shunichi Sugawara;
    • Satoshi Oizumi;
    • Hiroshi Isobe;
    • Akihiko Gemma;
    • Yasuo Saijo;
    • Hirohisa Yoshizawa;
    • Koichi Hagiwara;
    • Toshihiro Nukiwa
    Publication type:
    Article
    10
    11
    12

    Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial.

    Published in:
    2012
    By:
    • Oizumi, Satoshi;
    • Kobayashi, Kunihiko;
    • Inoue, Akira;
    • Maemondo, Makoto;
    • Sugawara, Shunichi;
    • Yoshizawa, Hirohisa;
    • Isobe, Hiroshi;
    • Harada, Masao;
    • Kinoshita, Ichiro;
    • Okinaga, Shoji;
    • Kato, Terufumi;
    • Harada, Toshiyuki;
    • Gemma, Akihiko;
    • Saijo, Yasuo;
    • Yokomizo, Yuki;
    • Morita, Satoshi;
    • Hagiwara, Koichi;
    • Nukiwa, Toshihiro
    Publication type:
    Journal Article
    13

    Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial.

    Published in:
    Oncologist, 2012, v. 17, n. 6, p. 863, doi. 10.1634/theoncologist.2011-0426
    By:
    • OIZUMI, SATOSHI;
    • KOBAYASHI, KUNIHIKO;
    • INOUE, AKIRA;
    • MAEMONDO, MAKOTO;
    • SUGAWARA, SHUNICHI;
    • YOSHIZAWA, HIROHISA;
    • ISOBE, HIROSHI;
    • HARADA, MASAO;
    • KINOSHITA, ICHIRO;
    • OKINAGA, SHOJI;
    • KATO, TERUFUMI;
    • HARADA, TOSHIYUKI;
    • GEMMA, AKIHIKO;
    • SAIJO, YASUO;
    • YOKOMIZO, YUKI;
    • MORITA, SATOSHI;
    • HAGIWARA, KOICHI;
    • NUKIWA, TOSHIHIRO
    Publication type:
    Article
    14
    15

    A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101).

    Published in:
    International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1060, doi. 10.1007/s10147-018-1318-z
    By:
    • Takashina, Taichi;
    • Asahina, Hajime;
    • Oizumi, Satoshi;
    • Yamada, Noriyuki;
    • Harada, Masao;
    • Takamura, Kei;
    • Yokouchi, Hiroshi;
    • Harada, Toshiyuki;
    • Honjo, Osamu;
    • Ogi, Takahiro;
    • Morikawa, Naoto;
    • Kinoshita, Ichiro;
    • Honda, Ryoichi;
    • Nakano, Kosuke;
    • Kanazawa, Kenya;
    • Amano, Toraji;
    • Dosaka-Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Nishimura, Masaharu;
    • Hokkaido Lung Cancer Clinical Study Group
    Publication type:
    Article
    16
    17

    Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials.

    Published in:
    Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2017.00972
    By:
    • Harada, Toshiyuki;
    • Amano, Toraji;
    • Ikari, Tomoo;
    • Takamura, Kei;
    • Ogi, Takahiro;
    • Fujikane, Toshiaki;
    • Fujita, Yuka;
    • Taima, Kageaki;
    • Tanaka, Hisashi;
    • Sasaki, Takaaki;
    • Okumura, Shunsuke;
    • Sugawara, Shunichi;
    • Yokouchi, Hiroshi;
    • Yamada, Noriyuki;
    • Morikawa, Naoto;
    • Dosaka-Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Nishimura, Masaharu
    Publication type:
    Article
    18
    19
    20
    21

    Tumor angiogenesis in human lung adenocarcinoma.

    Published in:
    1995
    By:
    • Kolin, Arnost;
    • Yamazaki, Kohichi;
    • Takekawa, Hironori;
    • Sukoh, Noriaki;
    • Watanabe, Naomi;
    • Ogura, Shigeaki;
    • Nakajima, Isao;
    • Isobe, Hiroshi;
    • Kawakami, Yoshikazu;
    • Abe, Shosaku;
    • Inoue, Kazuaki;
    • Kolin, A
    Publication type:
    commentary
    22

    Tumor angiogenesis in human lung adenocarcinoma.

    Published in:
    1994
    By:
    • Yamazaki, Kohichi;
    • Takekawa, Hironori;
    • Sukoh, Noriaki;
    • Watanabe, Naomi;
    • Ogura, Shigeaki;
    • Nakajima, Isao;
    • Isobe, Hiroshi;
    • Kawakami, Yoshikazu;
    • Abe, Shosaku;
    • Inoue, Kazuaki;
    • Yamazaki, K;
    • Abe, S;
    • Takekawa, H;
    • Sukoh, N;
    • Watanabe, N;
    • Ogura, S;
    • Nakajima, I;
    • Isobe, H;
    • Inoue, K;
    • Kawakami, Y
    Publication type:
    journal article
    23
    24
    25
    26
    27

    Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.

    Published in:
    Cancer Science, 2017, v. 108, n. 5, p. 1000, doi. 10.1111/cas.13225
    By:
    • Hida, Toyoaki;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Ohe, Yuichiro;
    • Nokihara, Hiroshi;
    • Sakai, Hiroshi;
    • Satouchi, Miyako;
    • Nakagawa, Kazuhiko;
    • Takenoyama, Mitsuhiro;
    • Isobe, Hiroshi;
    • Fujita, Shiro;
    • Tanaka, Hiroshi;
    • Minato, Koichi;
    • Takahashi, Toshiaki;
    • Maemondo, Makoto;
    • Takeda, Koji;
    • Saka, Hideo;
    • Goto, Koichi;
    • Atagi, Shinji;
    • Hirashima, Tomonori
    Publication type:
    Article
    28

    Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron.

    Published in:
    Cancer Science, 2015, v. 106, n. 7, p. 891, doi. 10.1111/cas.12675
    By:
    • Komatsu, Yoshito;
    • Okita, Kenji;
    • Yuki, Satoshi;
    • Furuhata, Tomohisa;
    • Fukushima, Hiraku;
    • Masuko, Hiroyuki;
    • Kawamoto, Yasuyuki;
    • Isobe, Hiroshi;
    • Miyagishima, Takuto;
    • Sasaki, Kazuaki;
    • Nakamura, Michio;
    • Ohsaki, Yoshinobu;
    • Nakajima, Junta;
    • Tateyama, Miki;
    • Eto, Kazunori;
    • Minami, Shinya;
    • Yokoyama, Ryoji;
    • Iwanaga, Ichiro;
    • Shibuya, Hitoshi;
    • Kudo, Mineo
    Publication type:
    Article
    29
    30

    A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703).

    Published in:
    2020
    By:
    • Fukumoto, Shin-ichi;
    • Oizumi, Satoshi;
    • Harada, Masao;
    • Sukoh, Noriaki;
    • Nakano, Kosuke;
    • Fuke, Satoshi;
    • Sakakibara-Konishi, Jun;
    • Takamura, Kei;
    • Ito, Kenichiro;
    • Fujita, Yuka;
    • Nishigaki, Yutaka;
    • Harada, Toshiyuki;
    • Akie, Kenji;
    • Kinoshita, Ichiro;
    • Amano, Toraji;
    • Isobe, Hiroshi;
    • Dosaka-Akita, Hirotoshi;
    • Nishimura, Masaharu;
    • Hokkaido Lung Cancer Clinical Study Group
    Publication type:
    journal article
    31

    A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002).

    Published in:
    2017
    By:
    • Ikezawa, Yasuyuki;
    • Asahina, Hajime;
    • Oizumi, Satoshi;
    • Watanabe, Masahiro;
    • Takamura, Kei;
    • Kawai, Yasutaka;
    • Yamada, Noriyuki;
    • Harada, Toshiyuki;
    • Kinoshita, Ichiro;
    • Fujita, Yuka;
    • Miyauchi, Eisaku;
    • Ogi, Takahiro;
    • Amano, Toraji;
    • Furuta, Megumi;
    • Sakakibara-Konishi, Jun;
    • Nishihara, Hiroshi;
    • Dosaka-Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Nishimura, Masaharu;
    • Hokkaido Lung Cancer Clinical Study Group
    Publication type:
    journal article
    32

    Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 6, p. 1149, doi. 10.1007/s00280-014-2589-3
    By:
    • Kanazawa, Kenya;
    • Yokouchi, Hiroshi;
    • Wang, Xintao;
    • Ishida, Takashi;
    • Fujita, Yuka;
    • Fujiuchi, Satoru;
    • Harada, Toshiyuki;
    • Harada, Masao;
    • Takamura, Kei;
    • Oizumi, Satoshi;
    • Kinoshita, Ichiro;
    • Katsuura, Yutaka;
    • Honjo, Osamu;
    • Kojima, Tetsuya;
    • Dosaka-Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Munakata, Mitsuru;
    • Nishimura, Masaharu
    Publication type:
    Article
    33

    Three‐year follow‐up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non‐small cell lung cancer: Pooled analysis of ONO‐4538‐05 and ONO‐4538‐06 studies.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 11, p. 5183, doi. 10.1002/cam4.2411
    By:
    • Horinouchi, Hidehito;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Saka, Hideo;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Sumiyoshi, Naoki
    Publication type:
    Article
    34
    35
    36
    37

    Symmetry and broken symmetry in molecular orbital description of unstable molecules IV: comparison between single- and multi-reference computational results for antiaromtic molecules.

    Published in:
    Theoretical Chemistry Accounts: Theory, Computation, & Modeling, 2011, v. 130, n. 4-6, p. 749, doi. 10.1007/s00214-011-0941-9
    By:
    • Saito, Toru;
    • Nishihara, Satomichi;
    • Yamanaka, Shusuke;
    • Kitagawa, Yasutaka;
    • Kawakami, Takashi;
    • Yamada, Satoru;
    • Isobe, Hiroshi;
    • Okumura, Mitsutaka;
    • Yamaguchi, Kizashi
    Publication type:
    Article
    38
    39
    40
    41
    42

    Characteristics and outcomes of patients with EGFR-mutation positive non-small-cell lung cancer receiving gefitinib beyond radiological progression.

    Published in:
    Expert Opinion on Pharmacotherapy, 2018, v. 19, n. 10, p. 1049, doi. 10.1080/14656566.2018.1484903
    By:
    • Hosomi, Yukio;
    • Tanai, Chiharu;
    • Yoh, Kiyotaka;
    • Goto, Yasushi;
    • Sakai, Hiroshi;
    • Kato, Terufumi;
    • Kaburagi, Takayuki;
    • Nishio, Makoto;
    • Kim, Young Hak;
    • Inoue, Akira;
    • Hasegawa, Yoshinori;
    • Isobe, Hiroshi;
    • Tomizawa, Yoshio;
    • Mori, Yoshiaki;
    • Minato, Koichi;
    • Yamada, Kazuhiko;
    • Ohashi, Yasuo;
    • Kunitoh, Hideo
    Publication type:
    Article
    43
    44
    45
    46

    Real-world data on the efficacy and safety of immune-checkpoint inhibitors in elderly patients with non-small cell lung cancer.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 10, p. 11525, doi. 10.1002/cam4.5889
    By:
    • Daisuke Morinaga;
    • Hajime Asahina;
    • Shotaro Ito;
    • Osamu Honjo;
    • Hisashi Tanaka;
    • Ryoichi Honda;
    • Hiroshi Yokouchi;
    • Keiichi Nakamura;
    • Kei Takamura;
    • Fumihiro Hommura;
    • Yasutaka Kawai;
    • Kenichiro Ito;
    • Noriaki Sukoh;
    • Keiki Yokoo;
    • Ryo Morita;
    • Toshiyuki Harada;
    • Taichi Takashina;
    • Tomohiro Goda;
    • Hirotoshi Dosaka-Akita;
    • Hiroshi Isobe
    Publication type:
    Article
    47
    48
    49
    50